• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Enzo Biochem Inc. (ENZ)

    -NYSE
    4.68 0.07(1.52%) Dec 18, 4:02PM EST
    Add to Portfolio
    Prev Close:4.61
    Open:4.66
    Bid:4.67 x 1300
    Ask:5.95 x 2000
    1y Target Est:7.00
    Beta:2.09
    Earnings Date:Mar 9 - Mar 13 (Est.)
    Day's Range:4.56 - 4.72
    52wk Range:2.58 - 6.13
    Volume:204,327
    Avg Vol (3m):199,036
    Market Cap:209.43M
    P/E (ttm):N/A
    EPS (ttm):-0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ENZUp 1.52%209.43M
    BRLI841.51M
    DGX9.48B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.13
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jul-15) :-0.23
    Quarterly EPS Est (Jan-15) :-0.09
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Enzo Biochem, Inc., an integrated life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback